Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

344 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference.
Hamre HJ, Pham VN, Kern C, Rau R, Klasen J, Schendel U, Gerlach L, Drabik A, Simon L. Hamre HJ, et al. Among authors: rau r. Patient Prefer Adherence. 2018 Mar 16;12:375-397. doi: 10.2147/PPA.S145221. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 29588576 Free PMC article.
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Detert J, Bastian H, Listing J, Weiß A, Wassenberg S, Liebhaber A, Rockwitz K, Alten R, Krüger K, Rau R, Simon C, Gremmelsbacher E, Braun T, Marsmann B, Höhne-Zimmer V, Egerer K, Buttgereit F, Burmester GR. Detert J, et al. Among authors: rau r. Ann Rheum Dis. 2013 Jun;72(6):844-50. doi: 10.1136/annrheumdis-2012-201612. Epub 2012 Jun 27. Ann Rheum Dis. 2013. PMID: 22739990 Clinical Trial.
An update on methotrexate.
Braun J, Rau R. Braun J, et al. Among authors: rau r. Curr Opin Rheumatol. 2009 May;21(3):216-23. doi: 10.1097/BOR.0b013e328329c79d. Curr Opin Rheumatol. 2009. PMID: 19373092 Review.
344 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page